Aehr Test Systems (AEHR) Registration Filing summary
Event summary combining transcript, slides, and related documents.
Registration Filing summary
16 Dec, 2025Company overview and business model
Develops and manufactures burn-in and test equipment for the semiconductor industry, serving a critical role in chip reliability and quality assurance.
Incorporated in California since 1977, with principal offices in Fremont, CA.
Financial performance and metrics
As of August 30, 2024, 29,583,732 shares of common stock were outstanding, with $75.6 million in net tangible book value ($2.56 per share).
After the offering, as adjusted net tangible book value would be $114.1 million, or $3.56 per share, assuming full sale at $16.02 per share.
Immediate dilution to new investors is estimated at $12.46 per share.
Use of proceeds and capital allocation
Net proceeds will be used for general corporate purposes, including working capital, inventory, R&D, commercial activities, and capital expenditures.
Management has broad discretion over the use of proceeds, which may not directly enhance operating results.
Latest events from Aehr Test Systems
- Advanced wafer-level test systems drive growth in AI, memory, and power semiconductor markets.AEHR
Corporate presentation23 Feb 2026 - AI and EV demand fuel growth as unique wafer-level testing secures market leadership.AEHR
17th Annual LD Micro Main Event Conference3 Feb 2026 - Record revenue and profit, strong 2025 outlook, and Incal acquisition drive growth in AI and GaN.AEHR
Q4 20243 Feb 2026 - Wafer level burn-in technology is expanding rapidly, driven by EVs, memory, and AI market growth.AEHR
The 44th Annual William Blair Growth Stock Conference1 Feb 2026 - Q1 revenue dropped 36% YoY, but margin rose to 54.7% as InCAL expands AI offerings.AEHR
Q1 202519 Jan 2026 - Wafer-level burn-in and automation fuel surging bookings in AI, memory, and photonics.AEHR
28th Annual Needham Growth Conference Virtual13 Jan 2026 - Q2 revenue fell 27%, but strong AI-driven bookings and improved cash signal a positive outlook.AEHR
Q2 202612 Jan 2026 - Revenue fell 37% but AI and GaN growth support $70M+ FY25 outlook amid market softness.AEHR
Q2 202510 Jan 2026 - AI and GaN orders, automation, and industry trends drive strong growth outlook and innovation.AEHR
27th Annual Needham Growth Conference10 Jan 2026